Lido Advisors, LLC Pulmonx Corp Transaction History

Lido Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.49 - $12.54 $14,980 - $25,080	-2,000 Reduced 12.84%	13,575 $151,000
Q4 2022 Feb 14, 2023	SELL	$4.92 - $17.35 $60,678 - $213,977	-12,333 Reduced 44.19%	15,575 $131,000
Q3 2022 Nov 14, 2022	SELL	$15.35 - $23.99 $2,256 - $3,526	-147 Reduced 0.52%	27,908 $464,000
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $2,058 - $4,108	147 Added 0.53%	28,055 $412,000
Q1 2022 May 17, 2022	BUY	$21.13 - $35.65 $30,025 - $50,658	1,421 Added 5.36%	27,908 $692,000
Q4 2021 Feb 15, 2022	SELL	$29.72 - $45.1 $134,453 - $204,032	-4,524 Reduced 14.59%	26,487 $849,000
Q3 2021 Nov 12, 2021	SELL	$35.98 - $44.48 $955,772 - $1.18 Million	-26,564 Reduced 46.14%	31,011 $1.12 Million
Q2 2021 Aug 12, 2021	BUY	$37.61 - $48.0 $2.17 Million - $2.76 Million	57,575 New	57,575 $2.54 Million

116

30.6M

400

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $309M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.